Form DEL AM - Delaying amendment
2024年2月26日 - 11:06PM
Edgar (US Regulatory)
BENITEC BIOPHARMA INC.
3940 Trust Way
Hayward, California
94545
February 26, 2024
VIA EDGAR
Securities and Exchange Commission
Division of
Corporation Finance
Office of Life Sciences
100 F Street,
N.E.
Washington, D.C. 20549
Re: |
Benitec Biopharma Inc. |
Registration Statement on Form S-3
File No. 333-277310
Ladies and Gentlemen:
Pursuant to Rule 473(c)
of the Securities Act of 1933 (the Act), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration Statement on Form
S-3 (File No. 333-277310) filed by Benitec Biopharma Inc. on February 23, 2024:
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until
the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration
Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
If you have any questions or comments in connection with this delaying amendment, please contact Louis Rambo (202) 416-6878 of Proskauer Rose LLP.
|
|
|
|
|
Very truly yours, |
|
BENITEC BIOPHARMA INC. |
|
|
By: |
|
/s/ Dr. Jerel Banks |
|
|
Name: Dr. Jerel Banks |
|
|
Title: Chief Executive Officer |
cc: |
Louis Rambo, Proskauer Rose LLP |
Benitec Biopharma (NASDAQ:BNTC)
過去 株価チャート
から 4 2024 まで 5 2024
Benitec Biopharma (NASDAQ:BNTC)
過去 株価チャート
から 5 2023 まで 5 2024